论文信息 - Medical Oncology Erlotinib Has Moderate Single-agent Activity in Chemotherapy-naïve Castration-resistant Prostate Cancer: Final Results of a Phase II Trial - 字舞流文

Medical Oncology Erlotinib Has Moderate Single-agent Activity in Chemotherapy-naïve Castration-resistant Prostate Cancer: Final Results of a Phase II Trial

C. Nabhan | S. Newman | J. Bitran | T. Lestingi | A. Galvez | D. Tsarwhas | K. Tolzien | Susan K. Kelby | Dean G. Tsarwhas | Dean Tsarwhas